Delfina key facts
as of Oct 2026- Developer of a data-driven pregnancy care platform designed to offer a personalized prenatal care system that keeps mothers and infants safe during pregnancy.
- Delfina is valued at approximately $52.0M as of Oct 2026 (last reported valuation).
- It has raised $24.5M; the latest was Early Stage VC ($17.0M) in Jan 2025.
- Notable investors include MassChallenge, Goodwater Capital, Harvard Innovation Launch Lab, E14 Fund, Matchstick Ventures — 21 tracked in total.
- Status: Privately Held (backing).
Delfina's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 21 names
- ·Watch Delfina: the Monday email on marks, rounds and moves
Delfina funding rounds
No funding rounds for Delfina are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Delfina
21+Delfina valuation
Delfina's last reported valuation was $52 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Delfina investors
21 investors are on record for Delfina, including MassChallenge, Goodwater Capital, Harvard Innovation Launch Lab and E14 Fund. By type, the record holds 5 venture capital firms.
About Delfina
Developer of a data-driven pregnancy care platform designed to offer a personalized prenatal care system that keeps mothers and infants safe during pregnancy. The company's platform optimizes interventional workflows using machine learning models, creates personalized pregnancy care plans based on patient risk from multiple metrics, and improves provider efficiency by supporting early intervention, enabling the healthcare industry to provide equitable and cost-effective pregnancy care.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 12
- Website
- delfina.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.